CD4 and COVID-19: Overall, our findings summarized a set of phenotypes feasible to be considered as potential predictors of COVID-19 outcome, including CD4+CD107a+, CD4+T-bet+, CD8+CD69+, CD8+T-bet+ and CD4+CD45RO+CD27+.